In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).

Abstract:

:The in vitro activities of quinupristin/dalfopristin (Synercid), ampicillin, erythromycin, clarithromycin, vancomycin, teicoplanin, ciprofloxacin and tetracycline were examined and compared against 526 gram-positive bacteria. The minimal inhibitory concentrations (MICs) for quinupristin/dalfopristin against Staphylococcus aureus, including methicillin-resistant strains, were low (MIC(90) = 0.5 mg/l), and were comparable with those of vancomycin and teicoplanin. This compound was superior to the macrolides and highly active against Streptococcus pneumoniae (both penicillin-sensitive and penicillin-resistant strains), with MIC(90) = 2 mg/l. It was also active against other streptococci, with MIC(90) = 4 mg/l. However, this agent is less active against enterococci (MIC(90) = 32 mg/l). Quinupristin/dalfopristin showed high activity against gram-positive anaerobes, including Clostridium spp., Peptococcus spp. and Peptostreptococcus spp., with MIC(90) < or = 2 mg/l. Quinupristin/dalfopristin was also investigated for its post-antibiotic effect (PAE) and bactericidal kinetics against nine strains of gram-positive organisms, including staphylococci, enterococci and pneumococci. Exponentially growing (log phase) cultures were exposed to quinupristin/dalfopristin at 2 x MIC. Growth kinetics was evaluated using viable counting. The drug was uniformly bactericidal against pneumococci and staphylococci within 2 and 8 h of exposure, respectively. The killing activity against enterococci was weak; there was little or no reduction in bacterial count over 24 h of incubation. PAEs ranging from 2.13 to 3.28 h, 0.92 to 3.02 h and 1.89 to 7.07 h were produced on the tested pneumococci, staphylococci and enterococci, respectively. This study showed that quinupristin/dalfopristin is a promising agent active against gram-positive bacteria. The prolonged PAEs also suggest that the drug could be used intermittently at more widely spaced dosing intervals against gram-positive organisms.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Ling TK,Fung KS,Cheng AF

doi

10.1159/000048530

subject

Has Abstract

pub_date

2001-07-01 00:00:00

pages

243-9

issue

4

eissn

0009-3157

issn

1421-9794

pii

48530

journal_volume

47

pub_type

杂志文章
  • Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity.

    abstract::The affinity of meropenem for various known types of beta-lactamases and its stability to them were tested in comparison with other beta-lactams, including imipenem. Meropenem exhibited a marked stability to all beta-lactamases tested and was only hydrolyzed by Xanthomonas maltophilia beta-lactamase, as were other bet...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239004

    authors: Nouda H,Harabe ET,Sumita Y,Okuda T,Fukasawa M

    更新日期:1992-01-01 00:00:00

  • Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.

    abstract::Addition of phenylbutazone (2 mg/ml) to 55 vol% of fresh defibrinated human blood permitted leukocytic ingestion of Serratia marcescens bacteria, but blocked phagocytic killing activity. The group A (phage tail) bacteriocin bA+ 16 served to kill extraphagocytic test bacteria. Five bacterial DNA gyrase inhibitors (cipr...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238297

    authors: Traub WH

    更新日期:1984-01-01 00:00:00

  • Effect of hydrocortisone and BCNU on long-term murine bone marrow cultures.

    abstract::Hydrocortisone (HC) has been observed to influence an in vitro Dexter culture system with maintenance of pluripotent hematopoietic stem cells (CFU-s) and progenitor cells (CFU-gm, BFU-e). In the present study, a two-phase murine Dexter culture system was established to study the mechanism of HC-mediated suppression of...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238340

    authors: Horikoshi A,Murphy MJ Jr

    更新日期:1985-01-01 00:00:00

  • Comparison between 5-fluorocytosine, amphotericin B and the combined administration of these agents in the therapeutic effectiveness for cryptococcal meningitis.

    abstract::Therapeutic effectiveness of 5-fluorocytosine (5-FC), amphotericin B (Am B) and both in combined administration were retrospectively assessed and compared with one another in 28 patients with cryptococcal meningitis. Combined administration was significantly superior to Am B alone and to 5-FC alone, and these agents w...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1159/000237811

    authors: Jimbow T,Tejima Y,Ikemoto H

    更新日期:1978-01-01 00:00:00

  • Renal sparing by amphotericin B colloidal dispersion: clinical experience in 572 patients.

    abstract::Data from five clinical trials of amphotericin B colloidal dispersion (ABCD) in the treatment of invasive mycoses were pooled to analyze the renal sparing effects of ABCD. Serum creatinine levels at baseline and either during or at end of treatment were available for 499 of 572 patients (87.2%). The median cumulative ...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000048469

    authors: Gurwith M,Mamelok R,Pietrelli L,Du Mond C

    更新日期:1999-06-01 00:00:00

  • Conditioning regimens including high-dose busulfan cause a high incidence of transplant-related mortality after myeloablative stem cell transplantation.

    abstract:BACKGROUND:Transplant-related mortality (TRM) significantly decreases the long-term survival of patients with hematopoietic diseases who undergo hematopoietic stem cell transplantation (HSCT). METHODS:We retrospectively evaluated the risk factors for TRM of 58 consecutive patients with hematopoietic disease who underw...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000080691

    authors: Nakamae H,Yamane T,Aoyama Y,Yamamura R,Ohta K,Hino M

    更新日期:2004-10-01 00:00:00

  • Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.

    abstract:BACKGROUND:This phase II study was conducted to evaluate the efficacy and safety of the chemotherapy combination of gemcitabine and vinorelbine in taxane-pretreated Japanese metastatic breast cancer patients. METHODS:In this multicenter, phase II, single-arm study, patients with recurrent or metastatic HER2-negative b...

    journal_title:Chemotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1159/000475879

    authors: Yamamura J,Masuda N,Yamamoto D,Tsuyuki S,Yamaguchi M,Tanaka S,Tsurutani J,Tokunaga S,Yoshidome K,Mizutani M,Aono T,Ooe A,Tanino H,Matsunami N,Yasojima H,Nakayama T,Nishida Y

    更新日期:2017-01-01 00:00:00

  • Potential interactions with anticancer agents: a cross-sectional study.

    abstract:BACKGROUND:Patients with cancer are particularly susceptible to drug interactions (DIs), but the extent of the problem has received limited attention. We aimed to evaluate the frequency of interactions with anticancer agents in a group of cancer patients. METHODS:The study was performed in a Belgian teaching hospital....

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000351133

    authors: Mouzon A,Kerger J,D'Hondt L,Spinewine A

    更新日期:2013-01-01 00:00:00

  • Effects of inner-membrane-associated beta-lactamase on penicillin-binding protein assays. Study of stably derepressed Pseudomonas aeruginosa strains from experimental endocarditis.

    abstract::We studied penicillin-binding protein (PBP) profiles of two Pseudomonas aeruginosa strains stably derepressed for constitutive, type Id beta-lactamase overproduction. Substantial levels of beta-lactamase were found to be strongly associated with isolated inner membranes of these two strains, as well as from a plasmid-...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238612

    authors: Parr TR Jr,Chan L,Bayer AS

    更新日期:1988-01-01 00:00:00

  • Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis.

    abstract:BACKGROUND:The combination of transarterial chemoembolization (TACE) and apatinib has been used in the treatment of intermediate or advanced hepatocellular carcinoma (HCC). However, its effectiveness and safety are also argued. METHODS:Eligible studies were collected from a computer search of literatures published fro...

    journal_title:Chemotherapy

    pub_type: 杂志文章,meta分析,评审

    doi:10.1159/000502510

    authors: Wei Y,Liu J,Yan M,Zhao S,Long Y,Zhang W

    更新日期:2019-01-01 00:00:00

  • Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.

    abstract:BACKGROUND:Chronic hepatitis B (CHB) affects 400 million people worldwide and is a major cause of morbidity and mortality. It is known that HBV DNA sequences were detected after the clearance of serum hepatitis B surface antigen (HBsAg) often in serum, liver and peripheral blood mononuclear cells. The objectives of our...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000109770

    authors: Akhan SC,Yulugkural Z,Vahaboglu H

    更新日期:2007-01-01 00:00:00

  • Pharmacokinetics of Benzylpenicillin (Penicillin G) during Prolonged Intermittent Renal Replacement Therapy.

    abstract::Prolonged intermittent renal replacement therapy (PIRRT) is an increasingly adopted method of renal replacement in critically ill patients. Like continuous renal replacement therapy, PIRRT can alter the pharmacokinetics (PK) of many drugs. In this setting, dosing data for antibiotics like benzylpenicillin are lacking....

    journal_title:Chemotherapy

    pub_type:

    doi:10.1159/000499375

    authors: Cheng V,Rawlins M,Chang T,Fox E,Dyer J,Allen C,Litton E,Page MM,Hoad K,Roberts JA

    更新日期:2019-01-01 00:00:00

  • Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer.

    abstract:BACKGROUND:The prognosis of patients with advanced gastric cancer (AGC) remains poor, and no single chemotherapy regimen is recognized as a global standard. A phase II trial was conducted to determine the efficacy and tolerability of capecitabine and oxaliplatin (XELOX) given every 3 weeks in combination in patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000305256

    authors: Luo HY,Xu RH,Wang F,Qiu MZ,Li YH,Li FH,Zhou ZW,Chen XQ

    更新日期:2010-01-01 00:00:00

  • Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.

    abstract:BACKGROUND:The glomerular filtration rate (GFR) is essential for calculating the dose and the monitoring of carboplatin. Although GFR measurement (mGFR) by external markers is ideal, in most cases these are not employed; the most used method is GFR estimation (eGFR) by formulae, hence the need to identify the formula w...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000488538

    authors: Graciano Vera N,Pino Villarreal L,Ureña Vargas J

    更新日期:2018-01-01 00:00:00

  • Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.

    abstract:BACKGROUNDS:The combination gemcitabine-oxaliplatin (GEMOX) is frequently used in patients with advanced biliary tract carcinoma (BTC). However, this is only based on phase II studies performed in selected patients.We assessed the efficacy and safety of the GEMOX regimen in non-selected patients with advanced BTC. MET...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000316848

    authors: Hollebecque A,Bouché O,Romano O,Scaglia E,Cattan S,Zerbib P,Heurgue A,Lagarde S,Mariette C,Triboulet JP,Pruvot FR,Hebbar M

    更新日期:2010-01-01 00:00:00

  • Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone.

    abstract::After metabolization, erdosteine (a mucoactive drug) produces an active metabolite (Met I) with an SH group that is capable of opening disulphide bonds, including those of pilin, a protein of bacterial fimbriae. This induces stereochemical conformational changes that interfere with the binding of bacterial adhesins (f...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000063223

    authors: Braga PC,Zuccotti T,Dal Sasso M

    更新日期:2001-05-01 00:00:00

  • In vitro activity of BMY-28142, a new cephalosporin.

    abstract::BMY-28142 was compared in vitro with ceftazidime, cefotaxime and cefoperazone and was found to be more active against Pseudomonas aeruginosa and Staphylococcus aureus. Essentially no effect of increasing inoculum size 100-fold was seen-on MICs with BMY-28142 or ceftazidime; some effect was noted with cefotaxime and ce...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238470

    authors: Norden CW,Neiderriter K

    更新日期:1987-01-01 00:00:00

  • Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.

    abstract::Minimal bactericidal concentrations of trimethoprim, nalidixic acid, and nitrofurantoin revealed effective intraphagolysosomal bactericidal activity against several assay strains of Serratia marcescens as determined with phenylbutazone-treated (2 mg/ml) fresh defibrinated human blood (55 vol%), following killing of ex...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238125

    authors: Traub WH

    更新日期:1982-01-01 00:00:00

  • Clinical applications of levofloxacin for severe infections.

    abstract::New fluoroquinolones, as exemplified by levofloxacin, possess broad spectrum activity against many common pathogens, including the majority responsible for respiratory tract infections (RTIs), atypical pathogens and those resistant to other therapeutic regimens. Following administration, levofloxacin attains high intr...

    journal_title:Chemotherapy

    pub_type: 杂志文章,评审

    doi:10.1159/000079818

    authors: Graninger W,Zeitlinger M

    更新日期:2004-01-01 00:00:00

  • Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience.

    abstract:BACKGROUND:The aim of this study was to evaluate the efficacy and tolerability of hepatic arterial infusion (HAI) of gemcitabine plus oxaliplatin as second-line treatment for unresectable locally advanced intrahepatic cholangiocarcinoma. PATIENTS AND METHODS:We retrospectively analyzed the outcome of 12 consecutive pa...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000362223

    authors: Ghiringhelli F,Lorgis V,Vincent J,Ladoire S,Guiu B

    更新日期:2013-01-01 00:00:00

  • Effects of isoniazid on viability, cell morphologies and acid fastness properties of Mycobacterium avium NCTC 8559 during the growth cycle.

    abstract::Our previous study demonstrated that the effects of isoniazid (INH) on Mycobacterium tuberculosis at the cellular level varied according to the growth phases. In this study, the variations in the INH action on M. avium strain NCTC 8559 are reported. M. avium cells grown on Middlebrook 7H10 agar were harvested at diffe...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000104470

    authors: Mohamad S,Ibrahim P,Wahab HA

    更新日期:2007-01-01 00:00:00

  • Virus inhibitory effect of combination of 9-(S)-(2,3-dihydroxypropyl) adenine and 6-azauridine.

    abstract::Combination of 9-(S)-(2,3-dihydroxypropyl)adenine [(S)-DHPA] and 6-azauridine (AzUrd) is highly active in the selective inhibition of vaccinia virus in chick embryo cell culture. Synergic effect of this combination of compounds was not encountered in HeLa cell culture. Of the 17 analogues related to DHPA studied in th...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237903

    authors: Rada B,Holý A

    更新日期:1980-01-01 00:00:00

  • A case of hemiballism as a rare side effect of ciprofloxacin in a patient with liver cirrhosis.

    abstract:BACKGROUND:Ciprofloxacin is commonly used and considered to be relatively safe in patients with cirrhosis, especially in the treatment of enteric and urinary tract infections. Among the adverse effects of ciprofloxacin, neurologic complications are rare. METHODS/RESULTS:We report a case of hemiballism and altered ment...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000218098

    authors: Kim SH,Jeong SH,Kim JW,Lee SH,Kim JM

    更新日期:2009-01-01 00:00:00

  • In vitro and in vivo antiplasmodial activity of Momordica balsamina alone or in a traditional mixture.

    abstract:BACKGROUND:Because of the dramatic situation of malaria in Africa, there is an urgent need to find new and cheap drugs, such as herbal medicines. Here we report the study of the in vitro and in vivo antimalarial activity of Momordica balsamina alone or in a traditional mixture used in Niger. METHODS:Extracts were obta...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000095960

    authors: Benoit-Vical F,Grellier P,Abdoulaye A,Moussa I,Ousmane A,Berry A,Ikhiri K,Poupat C

    更新日期:2006-01-01 00:00:00

  • Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.

    abstract::This investigation used the postantibiotic effect (PAE) and killing curves to provide data on the antimicrobial activity of subinhibitory (1/8x, 1/4x and 1/2x minimum inhibitory concentration; MIC) and inhibitory (1x MIC) concentrations of amikacin, gentamicin and tobramycin against Pseudomonas aeruginosa. Subinhibito...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238842

    authors: Zhanel GG,Karlowsky JA,Hoban DJ,Davidson RJ

    更新日期:1991-01-01 00:00:00

  • Bacterial growth kinetics of E. coli in the presence of various trimethoprim derivatives alone and in combination with sulfonamides.

    abstract::Bacterial growth kinetic experiments have been performed to study the potentiating effect of trimethoprim (TMP) AND TMP derivatives on the antibacterial action of sulfonamides (SA). The TMP derivatives showed different inhibitory effects when used alone. Derivatives with decreased inhibitory activity excerted 'bacteri...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237928

    authors: Seydel JK,Wempe E

    更新日期:1980-01-01 00:00:00

  • In vitro interactions of amikacin and beta-lactam antibiotics against amikacin-resistant gram-negative bacilli.

    abstract::We tested 42 strains of amikacin-resistant gram-negative bacilli with amikacin in combination with six beta-lactam antibiotics using the checkerboard and time-kill curve techniques. Synergism was demonstrated with time-killing curve in 43-68% of the strains tested. Ceftazidime plus amikacin was the most active combina...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238556

    authors: Alvarez S,Jones M,Holtsclaw-Berk S,Berk SL

    更新日期:1988-01-01 00:00:00

  • In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.

    abstract::The antibacterial activity of imipenem combined with norfloxacin, ciprofloxacin, or ofloxacin against 43 gram-positive cocci and 53 aerobic gram-negative rods compared to results obtained with the combination of imipenem with amikacin. Synergistic antibacterial action (defined as FIC index less than or equal to 0.5) w...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238558

    authors: Kern W,Gulden H,Vanek E,Kurrle E

    更新日期:1988-01-01 00:00:00

  • Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts.

    abstract:BACKGROUND/AIM:A phase 3 trial of S-1, leucovorin (LV), and oxaliplatin for treating gastric cancer is now underway. However, the antitumor efficacy of the combination has not yet been examined in an in vivo preclinical study. This study examined the antitumor efficacy of combination therapy consisting of S-1, LV, and ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000486029

    authors: Nagase H,Nakagawa F,Uchida J

    更新日期:2018-01-01 00:00:00

  • Use of the collagen gel droplet embedded drug sensitivity test to determine drug sensitivity against ovarian mature cystic teratoma with malignant transformation to adenocarcinoma: a case report.

    abstract:BACKGROUND:The collagen gel droplet embedded drug sensitivity test (CD-DST) is a new anticancer drug sensitivity test that only requires a small number of cells. We report the use of this test in the choice of adjuvant chemotherapy for treatment of a rare case of ovarian cancer involving malignant transformation of ova...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000099985

    authors: Yamagami W,Banno K,Kawaguchi M,Yanokura M,Kuwabara Y,Hirao N,Susumu N,Tsukazaki K,Aoki D

    更新日期:2007-01-01 00:00:00